Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease

This book aims to aid the selection of the most appropriate methods for use in early phase (1 and 2) clinical studies of new drugs for diabetes, obesity, non-alcoholic fatty liver disease (NAFLD) and related cardiometabolic disorders. Clinical research methods to assess the pharmacokinetics and pharmacodynamics of new diabetes drugs, e.g.

Aceasta carte analizeaza tehnicile de evaluare a actiunii insulinei, a secretiei de insulina si a compozitiei corpului, cu referire la medicamente noi, in studiile de faza 1 si 2. Se adauga la intelegerea efectelor medicamentelor si a strategiilor de tratament non-medicamentos la obezitate si diabetul de tip 2.